Accelerating Biotherapy and Personalized Medicine with Long DNA

SOURCE: Drug Discovery World Magazine

Matt Hill, Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development.